Publications by authors named "Taina Mattila"

Claim this Profile
I
Individual patient data meta-analysis of placebo-controlled trials of selective serotonin reuptake inhibitors submitted for regulatory approval in adult obsessive-compulsive disorder.
Sem E Cohen, Bram W Storosum, Jasper B Zantvoord, Taina K Mattila, Anthonius de Boer

Br J Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does early non-improvement predict treatment failure in pharmacotherapy for obsessive-compulsive disorder? A diagnostic test accuracy meta-analysis with individual participant data.
Sem Cohen, Jasper Brian Zantvoord, Ton de Boer, Taina Mattila, Guido van Wingen

Psychol Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-Analysis of Individual Participant Data: Randomized, Placebo-Controlled Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder.
Sem E Cohen, Anthonius de Boer, Bram W C Storosum, Taina K Mattila, Marisa J Niemeijer

J Am Acad Child Adolesc Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic differences in efficacy of drug treatment in patients with an acute manic episode: an individual patient data meta-analysis of randomized placebo-controlled trials.
Bram W C Storosum, Sem E Cohen, Cedrine A Steinz, Taina K Mattila, Carlijn C Welten

Int J Bipolar Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in the response to antipsychotics or mood stabilizers in patients with acute mania: An individual patient data meta-analysis of placebo-controlled studies.
Bram W C Storosum, Sem E Cohen, Taina K Mattila, Kit C B Roes, Carlijn Welten

J Psychiatr Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults.
Sem E Cohen, Jasper B Zantvoord, Taina K Mattila, Bram W C Storosum, Anthonius de Boer

Eur Psychiatry· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors.
Sem E Cohen, Damiaan A J P Denys, Taina Kristiina Mattila, Bram W C Storosum, Anthonius de Boer

BMJ Ment Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials.
Sem E Cohen, Jasper Brian Zantvoord, Bram W C Storosum, Taina Kristiina Mattila, Joost Daams

BMJ Ment Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers.
Florence Butlen-Ducuing, Marion Haberkamp, Georgios Aislaitner, Ewa Bałkowiec-Iskra, Taina Mattila

Eur Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The therapeutic potential of psychedelics: the European regulatory perspective.
Florence Butlen-Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp, Taina Mattila, Ewa Bałkowiec-Iskra

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board.
Bram W C Storosum, Cedrine Steinz, Sem E Cohen, Taina Mattila, Wim van den Brink

BJPsych Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies.
Bram W C Storosum, Taina Mattila, Tamar D Wohlfarth, Christine C Gispen-de Wied, Kit C B Roes

Psychiatry Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials.
Taina Mattila, Maarten Koeter, Tamar Wohlfarth, Jitschak Storosum, Wim van den Brink

Eur Neuropsychopharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.
Taina Mattila, Maarten Koeter, Tamar Wohlfarth, Jitschak Storosum, Wim van den Brink

Schizophr Bull· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia - an individual patient data meta-analysis.
Taina Mattila, Tamar Wohlfarth, Maarten Koeter, Jitschak Storosum, Wim van den Brink

Eur Neuropsychopharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insomnia medication: do published studies reflect the complete picture of efficacy and safety?
Taina Mattila, Violeta Stoyanova, André Elferink, Christine Gispen-de Wied, Anthonius de Boer

Eur Neuropsychopharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus.
Taina K Mattila, Anthonius de Boer

Drugs· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis